Gamida Cell Bounces Back With Omisirge US Approval

For Use In Hematological Malignancies

 
• By Ayisha Sharma
Stem Cells, 3D rendering. - Illustration
Omisirge Makes Use Of Gamida's NAM Technology • Source: Alamy

More from New Products

More from Scrip